The effects of mitiglinide KAD-1229, a new antidiabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide - Sunaga, Y; Gonoi, T; Shibasaki, T (Eur J Pharmacol, 2001)
Nov 9;